Fridbjörn Sigurdsson
National University Hospital of Iceland(IS)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, Genetic factors in colorectal cancer, Colorectal Cancer Screening and Detection, Glycosylation and Glycoproteins Research
Most-Cited Works
- → Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study(2012)528 cited
- → A germline variant in the TP53 polyadenylation signal confers cancer susceptibility(2011)303 cited
- → Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2(2017)121 cited
- → Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study(2017)81 cited
- → Granulocyte colony-stimulating factor induction of normal human bone marrow progenitors results in neutrophil-specific gene expression(1995)79 cited
- → Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin(2018)37 cited
- → Familial risk of colon and rectal cancer in Iceland: Evidence for different etiologic factors?(2006)21 cited
- → Screening for Monoclonal Gammopathy of Undetermined Significance: A Population-Based Randomized Clinical Trial. First Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study(2021)19 cited
- Control of late neutrophil-specific gene expression: insights into regulation of myeloid differentiation.(1997)
- → Detection of the factor V Leiden mutation in a nonselected black population [letter](1996)16 cited